Clinical protocols to monitor efficacy of [177Lu]Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer.

被引：0
|
作者：
Unterrainer, Lena [1 ]
De Leiris, Nicolas [2 ]
Unterrainer, Marcus [3 ]
Ilhan, Harun [4 ]
Delker, Astrid
Hempel, Linus
Ells, Zachary
Zahner, Joseph
Holzgreve, Adrien
Zacherl, Mathias J.
Casuscelli, Jozefina
Kiraz, Kevin
Leenhardt, Julien
Jacquet, Emmanuelle
Long, Jerome
Laramas, Mathieu
Paller, Channing Judith
Solnes, Lilja B.
Gafita, Andrei
Djaileb, Loic
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
[2] CHU Grenoble Alpes, Grenoble, France
[3] Ludwig Maximilians Univ Munchen, Dept Radiol, Munich, Germany
[4] Ludwig Maximilians Univ Munchen, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.39
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [1] Efficacy of systemic therapy following [177Lu] Lu-PSMA in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Kostos, Louise Kathleen
    Lai, William Yu Ching
    Lambroglou, Peter
    Medhurst, Elizabeth
    Buteau, James Patrick
    Sandhu, Shahneen
    Tran, Ben
    Spain, Lavinia Anne
    Conduit, Ciara
    Wallace, Roslyn
    Alipour, Ramin
    Akhurst, Timothy J.
    Kong, Grace
    Cardin, Anthony
    Saghebi, Javad
    Kumar, Aravind Ravi
    Hofman, Michael S.
    Azad, Arun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Philipp E. Hartrampf
    Franz-Xaver Weinzierl
    Andreas K. Buck
    Steven P. Rowe
    Takahiro Higuchi
    Anna Katharina Seitz
    Hubert Kübler
    Andreas Schirbel
    Markus Essler
    Ralph A. Bundschuh
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3269 - 3276
  • [3] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Buck, Andreas K.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Schirbel, Andreas
    Essler, Markus
    Bundschuh, Ralph A.
    Werner, Rudolf A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (09) : 3269 - 3276
  • [4] Treatment of castration-resistant metastatic prostate cancer with [177Lu]PSMA radioligand
    Sundset, Rune
    Haugnes, Hege Sagstuen
    Perez, Alexander
    Engelsen, Ola
    Fosseide, Ida H. H.
    Castillejo, Miguel J.
    Bogsrud, Trond Velde
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2024, 144 (09)
  • [5] Response to [177Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastases
    Zisser, Lucia
    Yu, Josef
    Oszwald, Andre
    Wollenweber, Tim
    Kretschmer-Chott, Elisabeth
    Grubmueller, Bernhard
    Kramer, Gero
    Shariat, Shahrokh F.
    Mitterhauser, Markus
    Vraka, Chrysoula
    Hacker, Marcus
    Haug, Alexander R.
    Rasul, Sazan
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (11) : 1113 - 1120
  • [6] Factors predicting the early biochemical response to [177Lu]Lu-PSMA therapy in patients with metastatic castration resistant prostate cancer
    Al-Timimi, Ahmed
    Manafi-Farid, Reyhaneh
    Fallahi, Babak
    Beiki, Davood
    Askari, Emran
    Rezaei, Alireza
    Adinehpour, Zohreh
    Eftekhari, Mohammad
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2022, 30 (02): : 115 - 121
  • [7] Combining enzalutamide and [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
    Houede, Nadine
    Hebert, Kevin
    LANCET ONCOLOGY, 2024, 25 (05): : 531 - 533
  • [8] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    BIOMEDICINES, 2021, 9 (04)
  • [9] RECIP 1.0 Predicts Progression-Free Survival After [ 177 Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
    Gafita, Andrei
    Djaileb, Loic
    Rauscher, Isabel
    Fendler, Wolfgang P.
    Hadaschik, Boris
    Rowe, Steven P.
    Herrmann, Ken
    Solnes, Lilja B.
    Calais, Jeremie
    Rettig, Matthew B.
    Weber, Manuel
    Farolfi, Andrea
    Benz, Matthias R.
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (06) : 917 - 922
  • [10] Therapy-related Myeloid Neoplasms Following Lutetium-177 [177Lu]Lu-PSMA Therapy in patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series
    Eifer, M.
    Sutherland, D. E. K.
    Goncalves, I.
    Buteau, J. P.
    Akhurst, T.
    Alipour, R.
    Au, L.
    Azad, A. A.
    Cardin, A.
    Chen, D.
    Emmerson, B.
    Emmett, L.
    Jewell, K.
    Kong, G.
    Kashyap, R.
    Kostos, L.
    Kumar, A. S. Ravi
    Kwan, E. M.
    Macfarlane, L.
    Medhurst, E.
    Saghebi, J.
    Sandhu, S.
    Tran, B.
    Wyatt, A. W.
    Hofman, M. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S677 - S677
12345